Patients receive ‘historic’ pill for deadly pancreatic cancer
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Patients receive ‘historic’ pill for deadly pancreatic cancer" is generating significant coverage in the Health category, with 6 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Pancreatic Cancer Action Network, Davis Journal, jonesborosun.com and Oncodaily. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 42d ago.
Quick answers
Why is "Patients receive ‘historic’ pill for deadly pancreatic cancer" trending?
Because 5 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Unlocking KRAS: Turning Science into Survival Pancreatic Cancer Action Network · 46d ago
- Intermountain Layton Hospital joins national initiative for new pancreatic cancer drug Davis Journal · 46d ago
- Unlocking KRAS: The Power of Advocacy Pancreatic Cancer Action Network · 46d ago
- Letter to the Editor jonesborosun.com · 46d ago
- Ryan Schoenfeld: How Pancreatic Tumors Develop Resistance to Daraxonrasib? Oncodaily · 46d ago
- Patients receive ‘historic’ pill for deadly pancreatic cancer The Boston Globe · 46d ago
Topics
Related trends
Scientists Studied 1,300 Cancer Patients, Then Found a Pattern in the Gut
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Patients are missing out on the cardiovascular benefits of blood pressure-lowering medicines, say researchers
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New Cancer Med Is Giving Patients Hope, But One Former Senator Says It Comes With A “Nasty” Catch
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Patients who suffer heart attack have more micro and nanoplastic in their blood
New research links the presence of micro and nanoplastics in the bloodstream to increased risks and severity of heart attacks.